Total Payments
$1,154
2024 Payments
$203.67
Companies
18
Transactions
58
Medicare Patients
5,061
Medicare Billing
$407,572
Payment Breakdown by Category
Food & Beverage$1,154 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,154 | 58 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $224.37 | 15 | $0 (2023) |
| Kiniksa Pharmaceuticals International, plc | $143.87 | 5 | $0 (2024) |
| Abbott Laboratories | $136.15 | 6 | $0 (2024) |
| iRhythm Technologies, Inc. | $134.02 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $118.18 | 8 | $0 (2024) |
| Medtronic, Inc. | $90.90 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $44.25 | 2 | $0 (2022) |
| Braemar Manufacturing, LLC | $43.08 | 1 | $0 (2018) |
| HeartFlow, Inc. | $42.18 | 1 | $0 (2022) |
| Philips Electronics North America Corporation | $35.42 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $203.67 | 11 | Kiniksa Pharmaceuticals International, plc ($50.71) |
| 2023 | $401.22 | 16 | iRhythm Technologies, Inc. ($102.43) |
| 2022 | $186.03 | 7 | Abbott Laboratories ($47.12) |
| 2021 | $71.75 | 5 | Abbott Laboratories ($37.32) |
| 2020 | $17.56 | 1 | Philips Electronics North America Corporation ($17.56) |
| 2019 | $53.50 | 4 | Regeneron Healthcare Solutions, Inc. ($15.65) |
| 2018 | $151.15 | 9 | E.R. Squibb & Sons, L.L.C. ($69.49) |
| 2017 | $69.04 | 5 | E.R. Squibb & Sons, L.L.C. ($69.04) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: Not Applicable | ||||||
| 06/27/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Not Applicable | ||||||
| 05/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/09/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/06/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: General - Therapies_CRM | ||||||
| 02/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/15/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Vascular | ||||||
| 02/08/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.58 | General |
| Category: Cardiovascular | ||||||
| 12/07/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $27.36 | General |
| Category: Not Applicable | ||||||
| 11/29/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2023 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/19/2023 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $78.26 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 08/29/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2023 | Philips Electronics North America Corporation | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $17.86 | General |
| Category: Medical Device | ||||||
| 07/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/07/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.89 | General |
| Category: Cardiovascular | ||||||
| 06/14/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $36.89 | General |
| Category: Not Applicable | ||||||
| 06/09/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $31.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/11/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| Category: Cardiovascular | ||||||
| 03/10/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $12.90 | General |
| Category: Heart Failure and Hypertension | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 903 | 1,494 | $380,882 | $95,161 |
| 2022 | 11 | 1,044 | 1,651 | $368,354 | $98,538 |
| 2021 | 12 | 1,258 | 2,003 | $536,533 | $110,049 |
| 2020 | 13 | 1,856 | 2,422 | $535,615 | $103,824 |
Total Patients
5,061
Total Services
7,570
Medicare Billing
$407,572
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 296 | 534 | $171,366 | $44,363 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 225 | 324 | $68,084 | $18,824 | 27.6% |
| 99424 | Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | Office | 2023 | 33 | 163 | $43,604 | $10,274 | 23.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 62 | 79 | $35,648 | $9,227 | 25.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $15,224 | $3,329 | 21.9% |
| 99425 | Principal care management services for a single high-risk disease, each additional 30 minutes provided personally by qualified health care professional, per calendar month | Office | 2023 | 21 | 57 | $9,667 | $2,568 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $16,223 | $2,437 | 15.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 185 | 243 | $12,782 | $2,198 | 17.2% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 28 | 41 | $8,284 | $1,940 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 304 | 598 | $176,650 | $50,362 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 267 | 351 | $67,164 | $19,015 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 59 | 71 | $29,678 | $9,296 | 31.3% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 26 | 144 | $26,455 | $6,066 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 55 | 55 | $26,555 | $5,570 | 21.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 263 | 347 | $16,922 | $3,412 | 20.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $8,870 | $1,838 | 20.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 20 | 20 | $6,413 | $966.08 | 15.1% |
| 99427 | Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 11 | 25 | $3,489 | $879.98 | 25.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $3,999 | $854.68 | 21.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 11 | 12 | $2,158 | $279.70 | 13.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 312 | 704 | $189,496 | $59,478 | 31.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 166 | 234 | $40,899 | $12,479 | 30.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 235 | 242 | $58,468 | $11,123 | 19.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 57 | 71 | $26,975 | $8,590 | 31.8% |
| G2065 | Comprehensive care management for a single high-risk disease services, e.g. principal care management, at least 30 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month with the following ele | Office | 2021 | 25 | 195 | $22,877 | $5,624 | 24.6% |
About Dr. Norman Ratliff, MD
Dr. Norman Ratliff, MD is a Cardiovascular Disease healthcare provider based in Silver City, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639130495.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Norman Ratliff, MD has received a total of $1,154 in payments from pharmaceutical and medical device companies, with $203.67 received in 2024. These payments were reported across 58 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,154).
As a Medicare-enrolled provider, Ratliff has provided services to 5,061 Medicare beneficiaries, totaling 7,570 services with total Medicare billing of $407,572. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Cardiovascular Disease
- Location Silver City, NM
- Active Since 03/31/2006
- Last Updated 02/02/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639130495
Products in Payments
- ELIQUIS (Drug) $190.90
- Arcalyst (Drug) $143.87
- ZIO XT Patch (Device) $134.02
- FARXIGA (Drug) $104.37
- LINQ II (Device) $78.26
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $47.12
- JARDIANCE (Drug) $44.25
- Cardiac Monitoring Suite (Device) $43.08
- FFRct (Device) $42.18
- CAMZYOS (Drug) $33.47
- Assurity Pacemaker (Device) $21.23
- MITRACLIP (Device) $20.21
- (5091) Amb Mon & Diag Und (Device) $17.86
- (7999) SRC Undivided (Device) $17.56
- JOT DX (Device) $16.80
- LEQVIO (Drug) $16.48
- MitraClip System (Device) $16.09
- PRALUENT (Biological) $15.65
- FLEXITOUCH (Device) $14.91
- MERLIN@HOME (Device) $14.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.